Endocrine Therapy-Induced Alopecia in Patients With Breast Cancer.

ABSTRACT:

Importance

Endocrine therapy-induced alopecia (EIA) has been anecdotally reported but not systematically described.

Objective

To characterize EIA in patients with breast cancer.

Design, setting, and participants

Retrospective cohort study of 112 patients with breast cancer, diagnosed with EIA from January 1, 2009, to December 31, 2016, the patients were examined at the dermatology service in a large tertiary care hospital and comprehensive cancer center.

Main outcomes and measures

The clinical features, alopecia-related quality of life (QoL), and response to minoxidil of EIA in patients with breast cancer were assessed. Data from the Hairdex Questionnaire was used to assess the impact of the alopecia on patients QoL. Higher score indicates lower QoL (0-100 scor

SUBMITTER: Freites-Martinez A 

PROVIDER: S-EPMC6145643 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature